Through innovative research on cancer treatment and prevention, members of the UBC Faculty of Medicine are attacking cancer on several fronts. Building from a rich tradition of discovery science, our people and partners are taking hold of new technologies and are exploring new areas of research to advance knowledge and improve care.
Skip to Stories
Discoveries
- 2017: New subtypes of ovarian cancer discovered
- 2017: Drug created from malaria parasite stops cancer in mice
- 2016: Gene linked to aggressive prostate cancer found
- 2016: Genetic mutations of rare gastric cancer found
- 2016: Human clinical trials start for new prostate cancer drug
- 2015: Scientists grow breast cancer from a single cancer cell
Spotlight
Artificial intelligence enhances ovarian cancer diagnostics
New AI technology developed by UBC researchers could improve diagnostics in remote communities that lack available specialists.
Read more >
UBC researchers part of international collaboration to develop treatments for osteosarcoma
The team developed new tools to understand how the cancerous cells spread and survive throughout the body.
Read more >
With just a tablespoon of blood, B.C. researchers aim to transform cancer treatment
The researchers have developed a new blood test that sequences the genome of tumour DNA in the blood, opening up new possibilities for personalized medicine.
Read more >
Cancer drug shows potential as treatment for muscular dystrophy
Experiments in mice show drug makes muscles fibres more resistant to damage characteristic of muscular dystrophy.
Read more >
Dr. Michael Kobor to lead new UBC research program in healthy aging
The Edwin S.H. Leong Healthy Aging Program is aimed at helping people live longer, healthier lives.
Read more >
B.C.-developed strategy reduces ovarian cancer risk: new study
Research shows that pre-emptive removal of the fallopian tubes, called opportunistic salpingectomy, will help save lives.
Read more >
New commentary confirms flaws in study that shaped current breast cancer screening guidelines
Researchers say trial results are unreliable and should not be used to inform policies on breast cancer screening.
Read more >
Chemotherapy drug puts young children with cancer at high risk of hearing loss
75 per cent of patients five years old and younger had experienced cisplatin-related hearing loss three years after starting therapy.
Read more >
New study examines ‘Achilles’ heel’ of cancer tumours, paving the way for new treatment strategies
UBC and BC Cancer researchers have uncovered a weakness in a key enzyme that solid tumour cancer cells rely on to adapt and survive.
Read more >
Clinical trial aims to improve outcomes for patients with colorectal cancer after surgery
The trial will assess whether a simple blood test can detect circulating tumour DNA after surgery.
Read more >